These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38589844)

  • 1. Association of the Advanced Lung Cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer.
    Jiang H; Li B; Wu M; Wang Q; Li Y
    BMC Cancer; 2024 Apr; 24(1):428. PubMed ID: 38589844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score.
    Li Y; Pan Y; Lin X; Hou J; Hu Z; Xu L; Zhou Z; Zhang Y; Chen M; Hu D
    Front Pharmacol; 2021; 12():819985. PubMed ID: 35237150
    [No Abstract]   [Full Text] [Related]  

  • 3. Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Biomarkers of Immune-Checkpoint Inhibitor for Non-Small Cell Lung Cancer.
    Minami S; Ihara S; Ikuta S; Komuta K
    World J Oncol; 2019 Apr; 10(2):90-100. PubMed ID: 31068989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of the Gustave Roussy Immune Score in Lung Cancer: A Meta-Analysis.
    Ji Y; Wang W
    Nutr Cancer; 2024 Jun; ():1-10. PubMed ID: 38841900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gustave Roussy Immune Score Is a Prognostic Factor for Chemotherapy-Naive Pulmonary Adenocarcinoma With Wild-Type Epidermal Growth Factor Receptor.
    Minami S; Ihara S; Komuta K
    World J Oncol; 2019 Feb; 10(1):55-61. PubMed ID: 30834052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gustave Roussy Immune Score as a Novel Prognostic Scoring System for Colorectal Cancer Patients: A Propensity Score Matching Analysis.
    Tian S; Cao Y; Duan Y; Liu Q; Peng P
    Front Oncol; 2021; 11():737283. PubMed ID: 34917499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of the Gustave Roussy immune (GRIm) score in cancer patients: a meta-analysis.
    Sun KX; Xu RQ; Rong H; Pang HY; Xiang TX
    Ann Med; 2023; 55(2):2236640. PubMed ID: 37851510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gustave Roussy Immune Score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer: A propensity score matching retrospective cohort study.
    Li SJ; Zhao L; Wang HY; Zhou HN; Ju J; Du H; Che GW
    Int J Surg; 2020 Dec; 84():25-40. PubMed ID: 33086147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab.
    Lenci E; Cantini L; Pecci F; Cognigni V; Agostinelli V; Mentrasti G; Lupi A; Ranallo N; Paoloni F; Rinaldi S; Nicolardi L; Caglio A; Aerts S; Cortellini A; Ficorella C; Chiari R; Di Maio M; Dingemans AC; Aerts JGJV; Berardi R
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33801320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy.
    Minichsdorfer C; Gleiss A; Aretin MB; Schmidinger M; Fuereder T
    Ann Med; 2022 Dec; 54(1):1339-1349. PubMed ID: 35535695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gustave Roussy immune score is a prognostic marker in patients with small cell lung cancer undergoing immunotherapy: a real-world retrospective study.
    Shangguan J; Huang X; Liu X; Zhang Z; Zhang X; Yu J; Chen D
    Front Oncol; 2023; 13():1195499. PubMed ID: 37205200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC-GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis.
    Hatanaka T; Naganuma A; Hiraoka A; Tada T; Hirooka M; Kariyama K; Tani J; Atsukawa M; Takaguchi K; Itobayashi E; Fukunishi S; Tsuji K; Ishikawa T; Tajiri K; Ochi H; Yasuda S; Toyoda H; Ogawa C; Nishimura T; Shimada N; Kawata K; Kosaka H; Kakizaki S; Tanaka T; Ohama H; Nouso K; Morishita A; Tsutsui A; Nagano T; Itokawa N; Okubo T; Arai T; Imai M; Koizumi Y; Nakamura S; Kaibori M; Iijima H; Hiasa Y; Kumada T;
    Cancer Med; 2023 Feb; 12(4):4259-4269. PubMed ID: 36156452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gustave Roussy Immune Score and Royal Marsden Hospital Prognostic Score Are Prognostic Markers for Extensive Disease of Small Cell Lung Cancer.
    Minami S; Ihara S; Komuta K
    World J Oncol; 2020 Jun; 11(3):98-105. PubMed ID: 32494316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer.
    Mountzios G; Samantas E; Senghas K; Zervas E; Krisam J; Samitas K; Bozorgmehr F; Kuon J; Agelaki S; Baka S; Athanasiadis I; Gaissmaier L; Elshiaty M; Daniello L; Christopoulou A; Pentheroudakis G; Lianos E; Linardou H; Kriegsmann K; Kosmidis P; El Shafie R; Kriegsmann M; Psyrri A; Andreadis C; Fountzilas E; Heussel CP; Herth FJ; Winter H; Emmanouilides C; Oikonomopoulos G; Meister M; Muley T; Bischoff H; Saridaki Z; Razis E; Perdikouri EI; Stenzinger A; Boukovinas I; Reck M; Syrigos K; Thomas M; Christopoulos P
    ESMO Open; 2021 Oct; 6(5):100254. PubMed ID: 34481329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gustave Roussy Immune Score (GRIm-Score) as a Prognostic and Predictive Score in Metastatic Colorectal Cancer.
    Cotan H; Iaciu C; Radu E; Niculae T; Rosu OA; Nitipir C
    Cureus; 2024 Apr; 16(4):e58935. PubMed ID: 38800241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive values of the hemoglobin, albumin, lymphocyte and platelet score (HALP) and the modified -Gustave Roussy immune score for esophageal squamous cell carcinoma patients undergoing concurrent chemoradiotherapy.
    Shi Y; Shen G; Zeng Y; Ju M; Chen X; He C; Liang L; Ge X; Sun X; Di X
    Int Immunopharmacol; 2023 Oct; 123():110773. PubMed ID: 37562292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Inflammation/Nutritional Status Scores Are Prognostic but Not Predictive in Metastatic Non-Small-Cell Lung Cancer Treated with First-Line Immune Checkpoint Inhibitors.
    Mahiat C; Bihin B; Duplaquet F; Stanciu Pop C; Dupont M; Vander Borght T; Rondelet B; Vanderick J; André B; Pirard L; Ocak S
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of Gustave Roussy immune score in operable pancreatic adenocarcinoma.
    Basoglu T; Babacan NA; Ozturk FE; Arikan R; Demircan NC; Telli TA; Ercelep O; Dane F; Yumuk PF
    Indian J Cancer; 2023; 60(2):179-184. PubMed ID: 36861712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysis.
    Xia H; Zhang W; Zhang Y; Shang X; Liu Y; Wang X
    Front Oncol; 2022; 12():978069. PubMed ID: 36330494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.